eye disease
Roche abandons oral drug for eye disease after phase 2 failure, shifts focus from solid tumor bispecifics
Anika Sharma
Roche’s ambitious quest to develop an oral treatment for diabetic retinopathy has faced a setback, as the company decided to ...
Eric Stonestreet, ‘Modern Family’ Actor, Joins Forces with Astellas’ Iveric Bio to Launch Vision Health Awareness Initiative
Anika Sharma
Iveric Bio, an Astellas-acquired biotech company, has initiated a compelling awareness campaign for a disease it recently gained FDA approval ...
Astellas claims positive results for Izervay in geographic atrophy but remains vague on data
Anika Sharma
Astellas, having recently secured FDA approval for its drug Izervay to treat geographic atrophy (GA), is now in direct competition ...
Novartis drops Gyroscope’s gene therapy for eye disease after disappointing trial results
Anika Sharma
Novartis is in the process of divesting its eye disease unit, a move that includes discontinuing a geographic atrophy (GA) ...
